News

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in…
Read More...

Caprion-HistoGeneX and Viroclinics-DDL announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions…
Read More...

Teva Pharmaceutical Industries Ltd. and biopharmaceutical company Alvotech today announced that they have entered into an exclusive strategic partnership for the commercialization in…
Read More...

GlaxoSmithKline plc announced the US Food and Drug Administration (FDA) has approved BLENREP (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed or…
Read More...

Evotec SE and the leading independent European antisense drug discovery company, Secarna Pharmaceuticals GmbH & Co. KG announced a strategic partnership in the field of antisense…
Read More...

Johnson & Johnson announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in…
Read More...

Pfizer Inc. announced that the Phase 3 CROWN study of LORBRENA (lorlatinib) in people with previously untreated advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung…
Read More...

Merck, known as MSD outside the United States and Canada, and Hanmi Pharmaceutical announced that the companies have entered into an exclusive licensing agreement for the development,…
Read More...

GS CORPORATION Japan's leading pharma wholesaler and distributor announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain…
Read More...

MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to…
Read More...

Catalent announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires. The expansion, which will add over 11,000 square feet of production space at the facility,…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Seismic Bio, Inc., an…
Read More...

ReViral Ltd., a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics that target respiratory syncytial virus (RSV),…
Read More...

Cellix Bio Pharma completes the acquisition of Avaca Pharma, a formulation development company. Avaca Pharma services include discovery, formulation development, regulatory support, and…
Read More...

G1 Therapeutics, Inc. and Simcere Pharmaceutical Group announced an exclusive license agreement for the development and commercialization of trilaciclib across all indications in…
Read More...

AbCellera announced that LY-CoV555, a human antibody discovered by AbCellera in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research…
Read More...

ImmunityBio, Inc. announced positive preclinical results for its human Ad5 vaccine candidate that contains both the spike (S) and nucleocapsid (N) SARS-CoV-2 proteins (hAd5 S + N) for…
Read More...

Innovent Biologics, Inc. announced that the first patient has been successfully dosed in a Phase 1 clinical trial (CIBI322A101) of the potentially first-in-class recombinant…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib) for the treatment of BRAF V600…
Read More...

Pfizer Inc. and BioNTech SE announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate…
Read More...